<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02942121</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00003585</org_study_id>
    <nct_id>NCT02942121</nct_id>
  </id_info>
  <brief_title>Application-based Perioperative Management of the Radical Cystectomy Patient</brief_title>
  <official_title>Application-based Perioperative Management of the Radical Cystectomy Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Kansas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn whether it is feasible to use the LifeScience
      Technologies application (LST app) in patients undergoing radical cystectomy with the
      eventual goal to reduce complications and readmissions to the hospital after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">February 14, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance using LST app at home</measure>
    <time_frame>90 Days</time_frame>
    <description>The LST app logs user activity. The study team will track user compliance with completing forms and questions within the application.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient-generated subjective global assessment (PG-SGA)</measure>
    <time_frame>Baseline</time_frame>
    <description>Test the PG-SGA using the LST app to see if it is feasible in practice at identifying patients at increased risk of malnutrition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Edmonton Frail Scale (EFS)</measure>
    <time_frame>Baseline</time_frame>
    <description>Test the EFS using the LST app to see if it is feasible in practice at identifying frail patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician Office/Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Survey Research (HealthStreamâ„¢)</measure>
    <time_frame>Change from Baseline to Day 90</time_frame>
    <description>Measure of how well the patient understood the various tests and procedures that were discussed with them before and after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of readmissions</measure>
    <time_frame>Day 90</time_frame>
    <description>Count of the number of readmissions to the hospital.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>LST App</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will use the LifeScience Technologies application (LST app) before surgery, and post surgery. Participants will use the app as an educational tool to learn more about their surgery. Participants will also answer questions about themselves in the app.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LifeScience Technologies application</intervention_name>
    <description>Application for mobile devices. The app enables users to review educational videos about a surgery and recovery from a surgery from home. It also enables the user to track different metrics specific to the user's health.</description>
    <arm_group_label>LST App</arm_group_label>
    <other_name>LST app</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of recurrent Non-muscle invasive bladder cancer (NMIBC) or Muscle-invasive
             Bladder Cancer (MIBC) and are candidates for radical cystectomy

          -  Subjects must have an internet connection and be able and willing to use an applicable
             device. If patients do not have an applicable device, they must be willing to borrow
             an iPad from the study team (to be returned at the conclusion of the study).

        Exclusion Criteria:

          -  No internet access
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugene Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kansas Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>October 20, 2016</study_first_submitted>
  <study_first_submitted_qc>October 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>January 30, 2019</last_update_submitted>
  <last_update_submitted_qc>January 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>surgery education</keyword>
  <keyword>radical cystectomy</keyword>
  <keyword>cystectomy</keyword>
  <keyword>muscle-invasive bladder cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

